Global /India /Healthcare /Drug Manufacturers - General /539730
chevron_leftBack
Fredun Pharmaceuticals Ltd. logo

Fredun Pharmaceuticals Ltd.

539730
BSE: 539730 Delayed
2,097.40INR -0.2%
22.21 USD
As of 20 June 2026, Fredun Pharmaceuticals Ltd. has a market cap of $122.5M USD, ranking #24160 globally and #1440 in India. It ranks #2168 in the Healthcare sector, and #785 in the Drug Manufacturers - General industry.
Global Rank
24160
Country Rank
1440
Sector Rank
2168
Industry Rank
785
Key Stats
Market Cap
$122.5MUSD
11.56B INR
Enterprise Value
$139.65MUSD
13.19B INR
Revenue (TTM)
$62.62MUSD
5.91B INR
EBITDA (TTM)
$8.54MUSD
806.28M INR
Net Income (TTM)
$3.46MUSD
326.79M INR
EBITDA Margin
14%
Profit Margin
5.5%
PE Ratio
29.8
PS Ratio
2.0
PB Ratio
7.4
EV/EBITDA
16.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
261
Founded
1987
Website
fredungroup.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.2% 0.8% 24% 40% 23% 199%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
539730 (FREDUN)
Fredun Pharmaceuticals Ltd
ISIN: INE194R01017
Shares Out.:
5.473M1 Shares Float: 2.65M2
TV:
SA:
YF:
GF:
BA:
MS:
2,097.40 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Fredun Pharmaceuticals Ltd.

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, anti-bacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, antibacterial, analgesics, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannula, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products. Fredun Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
37K%
39.1
DIVISLAB
$18.38B
1.73T INR
15K%
70.0
$15.17B
1.43T INR
12K%
63.0
$11.73B
1.11T INR
9K%
19.6
MANKIND
$9.87B
931.67B INR
8K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
8K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
622K%
38.1
JNJ
$547.28B
447K%
26.4
ABBV
$360.63B
294K%
97.4
$318.3B
256.25B CHF
260K%
19.9
AZN
$284.64B
215.59B GBP
232K%
27.6
MRK
$274.03B
224K%
15.1
chevron_leftBack